-
Feb 8, 2025 | 
msn.com | Leigh Ann Winick
Continue reading More for You
-
Feb 8, 2025 | 
cbsnews.com | Leigh Ann Winick |Sara Moniuszko
NFL has reduced concussions, Goodell says In this year's Super Bowl, Philadelphia star offensive tackle Jordan Mailata is hoping a new generation of helmets will help keep him in the game — avoiding the same fate as Buffalo Bills cornerback Christian Benford, who was sidelined after suffering a concussion in the AFC Championship weeks ago. "Headbutts are common, they're going to happen," Mailata said.
-
Sep 30, 2024 | 
cbsnews.com | Jon LaPook |Leigh Ann Winick
Spotlight on hospice as Jimmy Carter turns 100 This past spring, Joan Prum's advanced age and increasing frailty ushered in a new reality when she became a hospice patient. "I thought that unless you were really infirm and bedridden, you wouldn't be a candidate for hospice, but it turns out not to be true," Prum said. Healthcare teams provide comfort to hospice patients expected to live no longer than six months.
-
Sep 7, 2024 | 
cbsnews.com | Leigh Ann Winick |Adam Yamaguchi |Taylor Mooney
Ultra Processed | Food Tech & the American Diet Watch the CBS Reports documentary "Ultra Processed: How Food Tech Consumed the American Diet" in the video player above. HENDERSONVILLE, N.C. - Fifteen-year-old Tiara Channer was 13 when she was diagnosed with prediabetes — a condition 1 in 5 American kids faces that causes an increased risk of Type 2 diabetes, chronic kidney disease and cardiovascular disease. She and her mother, Crystal Cauley, blame her diagnosis on a poor diet.
-
Aug 12, 2024 | 
cbsnews.com | Celine Gounder |Leigh Ann Winick |Sara Moniuszko
A warmer climate means mosquito season is getting longer, prompting not only an increase in the pesky insects but also greater potential for them to spread diseases like West Nile virus. To help reduce the risk In New York City, expert "insect hunters" track the summer pests among the trees and marshes of parks that residents use to escape the summer heat.
-
Mar 13, 2024 | 
cbsnews.com | Sara Moniuszko |Leigh Ann Winick
U.S. strategy to end the HIV epidemic Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know it's an option. It's called pre-exposure prophylaxis, or PrEP, and it is about 99% effective to prevent HIV infection through sexual contact when taken as prescribed.
-
Jan 26, 2024 | 
news.yahoo.com | Stephen Stock |Leigh Ann Winick |Sara Moniuszko
Measles was officially declared eradicated in the U.S. more than 20 years ago, but new outbreaks of the disease are popping up — and experts say declining vaccination rates are jeopardizing herd immunity and increasing the risk. In Philadelphia, nine cases were reported after a cluster started in a hospital and spread to other medical facilities and a day care center. Measles is a highly contagious and potentially deadly virus that causes a tell-tale rash.
-
Jan 23, 2024 | 
cbsnews.com | Stephen Stock |Leigh Ann Winick |Sara Moniuszko
What's causing measles outbreaks? Measles was officially declared eradicated in the U.S. more than 20 years ago, but new outbreaks of the disease are popping up — and experts say declining vaccination rates are jeopardizing herd immunity and increasing the risk. In Philadelphia, nine cases were reported after a cluster started in a hospital and spread to other medical facilities and a day care center.
-
Dec 11, 2023 | 
autos.yahoo.com | Jonathan LaPook |Leigh Ann Winick |Analisa Novak
The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease. The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease.
-
Dec 11, 2023 | 
yahoo.com | Jonathan LaPook |Leigh Ann Winick |Analisa Novak
The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease. The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease.
